Sectoral Asset Management Inc Karuna Therapeutics, Inc. Transaction History

Sectoral Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$161.01 - $317.85 $3.82 Million - $7.55 Million	-23,745 Reduced 91.4%	2,235 $707,000
Q3 2023 Nov 14, 2023	BUY	$164.66 - $218.08 $40,835 - $54,083	248 Added 0.96%	25,980 $4.39 Million
Q2 2023 Aug 11, 2023	SELL	$176.32 - $240.22 $202,415 - $275,772	-1,148 Reduced 4.27%	25,732 $5.58 Million
Q1 2023 May 12, 2023	BUY	$161.33 - $204.36 $817,943 - $1.04 Million	5,070 Added 23.25%	26,880 $4.88 Million
Q4 2022 Feb 10, 2023	BUY	$191.53 - $236.82 $478,825 - $592,050	2,500 Added 12.95%	21,810 $4.29 Million
Q3 2022 Nov 10, 2022	SELL	$123.79 - $277.42 $583,050 - $1.31 Million	-4,710 Reduced 19.61%	19,310 $4.34 Million
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $2.26 Million - $3.44 Million	24,020 New	24,020 $3.04 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.